Nalaganje...
Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects
Posaconazole is a potent, broad-spectrum triazole antifungal agent currently in clinical development for the treatment of refractory invasive fungal infections. Eight healthy male subjects received a single 399-mg (81.7 μCi) oral dose of [(14)C]posaconazole after consuming a high-fat breakfast. Urin...
Shranjeno v:
| izdano v: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
2004
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC514780/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15328123/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.9.3543-3551.2004 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|